5917 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 119 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AMICA1Adhesion molecule, interacts with CXADR antigen 1
Head and neck cancer: 3.11e-4
Lung cancer: 3.92e-4
Tissue enhancedappendix:84.3
AMIGO1Adhesion molecule with Ig-like domain 1
Nucleoplasm
Nuclear bodies
Liver cancer: 1.21e-4
Mixed
AMIGO2Adhesion molecule with Ig-like domain 2
Golgi apparatus
Plasma membrane
Cytosol
Pancreatic cancer: 1.80e-4
Mixed
AMIGO3Adhesion molecule with Ig-like domain 3N/A
Mixed
AMNAmnion associated transmembrane protein
Renal cancer: 9.62e-5
Group enriched6colon:20.4
duodenum:35.1
kidney:29.0
small intestine:72.0
AMPD2Adenosine monophosphate deaminase 2
CytosolRenal cancer: 3.78e-10
Expressed in all
ANAPC1Anaphase promoting complex subunit 1
VesiclesEndometrial cancer: 1.34e-4
Expressed in all
ANAPC4Anaphase promoting complex subunit 4
Intermediate filamentsEndometrial cancer: 5.73e-7
Urothelial cancer: 1.12e-6
Renal cancer: 1.17e-5
Head and neck cancer: 1.95e-4
Expressed in all
ANGPTL1Angiopoietin-like 1
Renal cancer: 5.11e-4
Liver cancer: 8.73e-4
Tissue enhancedplacenta:188.3
ANGPTL3Angiopoietin-like 3
Tissue enriched6liver:356.2
ANK1Ankyrin 1, erythrocytic
Tissue enhancedparathyroid gland:83.0
skeletal muscle:348.3
ANKARAnkyrin and armadillo repeat containingN/A
Nucleus
Microtubule organizing center
Tissue enriched7testis:10.2
ANKHANKH inorganic pyrophosphate transport regulator
CytosolGlioma: 7.64e-4
Expressed in all
ANKLE2Ankyrin repeat and LEM domain containing 2
Endoplasmic reticulum
Plasma membrane
Renal cancer: 1.90e-8
Liver cancer: 3.97e-6
Expressed in all
ANKRD18BAnkyrin repeat domain 18BN/A
Nucleoli
Cytosol
Tissue enhancedtestis:6.8
ANKRD27Ankyrin repeat domain 27 (VPS9 domain)
CytosolLiver cancer: 1.21e-5
Endometrial cancer: 8.68e-4
Expressed in all
ANKRD29Ankyrin repeat domain 29N/A
Nucleoplasm
Nuclear bodies
Head and neck cancer: 1.92e-5
Lung cancer: 5.98e-5
Renal cancer: 7.20e-5
Mixed
ANKRD42Ankyrin repeat domain 42N/A
Nucleoplasm
Plasma membrane
Cytosol
Tissue enhancedtestis:71.7
ANKRD46Ankyrin repeat domain 46
CytosolExpressed in all
ANO1Anoctamin 1, calcium activated chloride channel
Renal cancer: 4.09e-6
Endometrial cancer: 4.58e-6
Head and neck cancer: 7.28e-5
Pancreatic cancer: 1.70e-4
Lung cancer: 2.40e-4
Tissue enhancedepididymis:217.7
seminal vesicle:295.7
ANO10Anoctamin 10
Renal cancer: 6.41e-6
Endometrial cancer: 1.11e-4
Liver cancer: 3.19e-4
Colorectal cancer: 6.70e-4
Expressed in all
ANO2Anoctamin 2, calcium activated chloride channel
Nucleoplasm
Plasma membrane
Tissue enhancedtestis:17.7
ANO3Anoctamin 3
Tissue enriched6epididymis:61.3
ANO4Anoctamin 4N/A
Renal cancer: 5.48e-5
Group enriched6adrenal gland:17.6
cerebral cortex:10.0
cervix, uterine:12.5
endometrium:8.3
ovary:10.9
prostate:10.9
seminal vesicle:11.3
ANO5Anoctamin 5
Renal cancer: 2.50e-7
Tissue enhancedparathyroid gland:55.2
ANO6Anoctamin 6
Plasma membrane
Cytosol
Breast cancer: 7.56e-5
Cervical cancer: 3.82e-4
Expressed in all
ANO7Anoctamin 7
Tissue enhancedprostate:86.9
stomach:26.2
ANO8Anoctamin 8
Nucleoplasm
Nucleoli fibrillar center
Tissue enhancedcerebral cortex:34.6
ANO9Anoctamin 9
Golgi apparatusUrothelial cancer: 8.81e-4
Tissue enhancedduodenum:32.4
small intestine:31.6
ANPEPAlanyl (membrane) aminopeptidase
Nucleus
Plasma membrane
Group enriched9duodenum:2451.4
small intestine:2177.9
ANTXR1Anthrax toxin receptor 1
VesiclesThyroid cancer: 1.22e-5
Cervical cancer: 5.76e-4
Mixed
AOAHAcyloxyacyl hydrolase (neutrophil)
Tissue enhancedspleen:90.2
AOC1Amine oxidase, copper containing 1
Prostate cancer: 1.71e-4
Tissue enhancedplacenta:711.7
small intestine:257.2
AOC2Amine oxidase, copper containing 2 (retina-specific)N/A
Urothelial cancer: 2.47e-4
Tissue enhancedadipose tissue:6.2
testis:5.9
AOC3Amine oxidase, copper containing 3
Golgi apparatus
Cytosol
Renal cancer: 1.79e-5
Colorectal cancer: 3.68e-4
Urothelial cancer: 6.98e-4
Tissue enhancedadipose tissue:449.0
AP000322.53N/A
Group enriched6breast:3.3
fallopian tube:3.2
kidney:8.7
AP000350.10N/A
Not detected
AP3B1Adaptor-related protein complex 3, beta 1 subunit
Nucleoplasm
Golgi apparatus
Renal cancer: 7.97e-6
Colorectal cancer: 1.37e-5
Expressed in all
AP4B1Adaptor-related protein complex 4, beta 1 subunit
VesiclesLiver cancer: 8.60e-7
Renal cancer: 3.73e-6
Expressed in all
AP5B1Adaptor-related protein complex 5, beta 1 subunit
Nucleus
Golgi apparatus
Vesicles
Renal cancer: 2.31e-5
Expressed in all
AP5S1Adaptor-related protein complex 5, sigma 1 subunit
Nucleoplasm
Cytosol
Renal cancer: 5.53e-5
Expressed in all
APCDD1LAdenomatosis polyposis coli down-regulated 1-likeN/A
MitochondriaTissue enhancedbreast:6.5
salivary gland:11.7
APCSAmyloid P component, serum
Tissue enriched25liver:1844.2
APH1AAPH1A gamma secretase subunit
Expressed in all
APLFAprataxin and PNKP like factor
NucleoplasmMixed
APLNRApelin receptor
Group enriched5cerebral cortex:82.9
placenta:145.6
spleen:164.2
APLP1Amyloid beta (A4) precursor-like protein 1
Urothelial cancer: 2.65e-5
Endometrial cancer: 3.87e-4
Tissue enriched13cerebral cortex:441.8
APLP2Amyloid beta (A4) precursor-like protein 2
VesiclesRenal cancer: 1.33e-9
Thyroid cancer: 2.90e-4
Liver cancer: 3.37e-4
Expressed in all
APMAPAdipocyte plasma membrane associated protein
Plasma membraneExpressed in all
APOA1Apolipoprotein A-I
Vesicles
Cytosol
Renal cancer: 1.67e-8
Liver cancer: 5.05e-4
Tissue enhancedliver:8446.1
small intestine:4222.2

« prev | Page of 119 | next »